MEA Refractive Surgery Devices Market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET 28
1.4 LIMITATIONS 30
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 PRODUCT TYPE LIFELINE CURVE 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 MARKET APPLICATION COVERAGE GRID 42
2.11 VENDOR SHARE ANALYSIS 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 48
4.1 PESTEL'S MODEL 50
4.2 PORTER'S FIVE FORCES MODEL 51
4.3 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: REGULATIONS 52
4.3.1 REGULATION IN THE U.S. 52
4.3.2 REGULATIONS IN EUROPE 53
4.3.3 REGULATIONS IN SINGAPORE 53
4.3.4 REGULATIONS IN AUSTRALIA 54
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 INCREASING TECHNOLOGICAL ADVANCEMENT 57
5.1.2 RISE IN HEALTHCARE EXPENDITURE 57
5.1.3 INCREASE IN POPULATION WITH MACULAR DEGENERATION 57
5.1.4 RISE IN ADOPTION OF MINIMALLY INVASIVE SURGERIES 58
5.2 RESTRAINTS 58
5.2.1 STRINGENT RULES AND REGULATIONS 58
5.2.2 HIGH COST ASSOCIATED WITH REFRACTIVE SURGERY DEVICES 59
5.2.3 SIDE EFFECTS OF SURGERY 59
5.3 OPPORTUNITIES 61
5.3.1 ACHIEVEMENTS IN LASIK SURGERIES 61
5.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
5.3.3 INCREASING GERIATRIC POPULATION 62
5.3.4 EXCESSIVE USAGE OF DIGITAL DEVICES 62
5.4 CHALLENGES 64
5.4.1 DEARTH OF SKILLED PROFESSIONALS 64
5.4.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT 64
6 COVID-19 IMPACT ON MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET 65
6.1 IMPACT ON PRICE 65
6.2 IMPACT ON DEMAND 65
6.3 IMPACT ON SUPPLY 66
6.4 STRATEGIC DECISIONS BY MANUFACTURERS 66
6.5 CONCLUSION 67
7 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE 68
7.1 OVERVIEW 69
7.2 LASER 72
7.2.1 EXCIMER LASERS 73
7.2.2 FEMTOSECOND LASER/ULTRASHORT PULSE LASER 73
7.2.3 OTHERS 74
7.3 PHAKIC INTRAOCULAR LENS (IOL) 74
7.4 ABERROMETERS / WAVEFRONT ABERROMETRY 75
7.5 SURGICAL INSTRUMENTS & ACCESSORIES 75
7.6 REFRACTIVE SURGERY KITS 76
7.7 PUPILLARY DIAMETER METERS 77
7.8 EPIKERATOMES 78
7.9 MICROKERATOMES 79
7.10 THERMOKERATOPLASTY 79
7.11 LIMBAL RELAXING INCISION KITS 80
7.12 OTHERS 81
8 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY SURGERY TYPE 83
8.1 OVERVIEW 84
8.2 LASIK (LASER IN-SITU KERATOMILEUSIS) 87
8.3 PHOTOREFRACTIVE KERATECTOMY (PRK) 88
8.4 PHAKIC INTRAOCULAR LENSES (IOL) 89
8.5 ASTIGMATIC KERATOTOMY (AK) 90
8.6 AUTOMATED LAMELLAR KERATOPLASTY (ALK) 91
8.7 INTRACORNEAL RING (INTACS) 92
8.8 LASER THERMAL KERATOPLASTY (LTK) 93
8.9 CONDUCTIVE KERATOPLASTY (CK) 94
8.10 RADIAL KERATOTOMY (RK) 95
8.11 OTHERS 96
9 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY APPLICATION 98
9.1 OVERVIEW 99
9.2 NEARSIGHTEDNESS (MYOPIA) 102
9.3 FARSIGHTEDNESS (HYPEROPIA) 102
9.4 PRESBYOPIA 103
9.5 ASTIGMATISM 104
10 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY END USER 106
10.1 OVERVIEW 107
10.2 HOSPITAL 110
10.3 SPECIALTY CLINICS 110
10.4 AMBULATORY SURGICAL CENTERS 111
10.5 OTHERS 112
11 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY DISTRIBUTION CHANNEL 113
11.1 OVERVIEW 114
11.2 DIRECT TENDER 117
11.3 THIRD PARTY DISTRIBUTORS 117
11.4 OTHERS 118

12 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY REGION 120
12.1 MIDDLE EAST AND AFRICA 121
12.1.1 SOUTH AFRICA 128
12.1.2 SAUDI ARABIA 131
12.1.3 U.A.E. 134
12.1.4 EGYPT 137
12.1.5 ISRAEL 140
12.1.6 KUWAIT 143
12.1.7 REST OF MIDDLE EAST AND AFRICA 146
13 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: COMPANY LANDSCAPE 147
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 147
14 SWOT ANALYSIS 148
15 COMPANY PROFILE 149
15.1 JOHNSON AND JOHNSON SERVICES, INC. 149
15.1.1 COMPANY SNAPSHOT 149
15.1.2 REVENUE ANALYSIS 149
15.1.3 COMPANY SHARE ANALYSIS 150
15.1.4 PRODUCT PORTFOLIO 151
15.1.5 RECENT DEVELOPMENT 151
15.1.5.1 PRODUCT LAUNCH 151
15.2 ALCON INC. 152
15.2.1 COMPANY SNAPSHOT 152
15.2.2 REVENUE ANALYSIS 153
15.2.3 COMPANY SHARE ANALYSIS 153
15.2.4 PRODUCT PORTFOLIO 154
15.2.5 RECENT DEVELOPMENTS 154
15.2.5.1 ACQUISITION 154
15.2.5.2 PRODUCT LAUNCH 155
15.3 STAAR SURGICAL 156
15.3.1 COMPANY SNAPSHOT 156
15.3.2 REVENUE ANALYSIS 156
15.3.3 COMPANY SHARE ANALYSIS 157
15.3.4 PRODUCT PORTFOLIO 157
15.3.5 RECENT DEVELOPMENTS 158

15.4 BAUSCH + LOMB INCORPORATED 159
15.4.1 COMPANY SNAPSHOT 159
15.4.2 REVENUE ANALYSIS 159
15.4.3 COMPANY SHARE ANALYSIS 160
15.4.4 PRODUCT PORTFOLIO 160
15.4.5 RECENT DEVELOPMENT 161
15.4.5.1 ACQUISITION 161
15.4.5.2 CE APPROVAL 161
15.5 TOPCON CANADA INC., (A SUBSIDIARY OF TOPCON CORPORATION) 162
15.5.1 COMPANY SNAPSHOT 162
15.5.2 REVENUE ANALYSIS 162
15.5.3 COMPANY SHARE ANALYSIS 163
15.5.4 PRODUCT PORTFOLIO 163
15.5.5 RECENT DEVELOPMENTS 164
15.5.5.1 PARTNERSHIP 164
15.5.5.2 ACQUISITION 165
15.6 AAREN SCIENTIFIC INC. 166
15.6.1 COMPANY SNAPSHOT 166
15.6.2 PRODUCT PORTFOLIO 167
15.6.3 RECENT DEVELOPMENT 167
15.7 AMPLITUDE LASER 168
15.7.1 COMPANY SNAPSHOT 168
15.7.2 PRODUCT PORTFOLIO 168
15.7.3 RECENT DEVELOPMENTS 168
15.7.3.1 PARTNERSHIP 169
15.8 BD 171
15.8.1 COMPANY SNAPSHOT 171
15.8.2 REVENUE ANALYSIS 171
15.8.3 PRODUCT PORTFOLIO 172
15.8.4 RECENT DEVELOPMENTS 172
15.8.4.1 CONFERENCE 172
15.8.4.2 PRODUCT LAUNCH 172
15.9 GLAUKOS CORPORATION 173
15.9.1 COMPANY SNAPSHOT 173
15.9.2 REVENUE ANALYSIS 173
15.9.3 PRODUCT PORTFOLIO 174
15.9.4 RECENT DEVELOPMENTS 174
15.9.4.1 PRODUCT LAUNCH 174
15.9.4.2 ACQUISITION 175

15.10 HOYA SURGICAL OPTICS 176
15.10.1 COMPANY SNAPSHOT 176
15.10.2 PRODUCT PORTFOLIO 176
15.10.3 RECENT DEVELOPMENT 177
15.10.3.1 CONFERENCE 177
15.11 IVIS TECHNOLOGIES 178
15.11.1 COMPANY SNAPSHOT 178
15.11.2 PRODUCT PORTFOLIO 178
15.11.3 RECENT DEVELOPMENTS 179
15.12 LENSAR INC. (A SUBSDIARY OF PDL BIOPHARMA, INC.) 180
15.12.1 COMPANY SNAPSHOT 180
15.12.2 PRODUCT PORTFOLIO 180
15.12.3 RECENT DEVELOPMENTS 180
15.13 MORIA 181
15.13.1 COMPANY SNAPSHOT 181
15.13.2 PRODUCT PORTFOLIO 182
15.13.3 RECENT DEVELOPMENT 182
15.14 NIDEK CO., LTD 183
15.14.1 COMPANY SNAPSHOT 183
15.14.2 PRODUCT PORTFOLIO 183
15.14.3 RECENT DEVELOPMENT 183
15.14.3.1 WEBSITE LAUNCH 183
15.15 OPHTEC BV 184
15.15.1 COMPANY SNAPSHOT 184
15.15.2 PRODUCT PORTFOLIO 184
15.15.3 RECENT DEVELOPMENT 185
15.15.3.1 PRODUCT LAUNCH 185
15.16 RAYNER INTRAOCULAR LENSES LIMITED 186
15.16.1 COMPANY SNAPSHOT 186
15.16.2 PRODUCT PORTFOLIO 186
15.16.3 RECENT DEVELOPMENTS 186
15.16.3.1 NEW DISTRIBUTION UNIT 186
15.16.3.2 ACQUISITION 187
15.16.3.3 ACQUISITION 187
15.17 REICHERT, INC. 188
15.17.1 COMPANY SNAPSHOT 188
15.17.2 PRODUCT PORTFOLIO 188
15.17.3 RECENT DEVELOPMENT 188
15.17.3.1 CONFERENCE 188

15.18 ROWIAK GMBH 189
15.18.1 COMPANY SNAPSHOT 189
15.18.2 PRODUCT PORTFOLIO 189
15.18.3 RECENT DEVELOPMENT 189
15.18.3.1 R&D FACILITY 189
15.19 SCHWIND EYE-TECH-SOLUTIONS 190
15.19.1 COMPANY SNAPSHOT 190
15.19.2 PRODUCT PORTFOLIO 190
15.19.3 RECENT DEVELOPMENTS 191
15.20 TRACEY TECHNOLOGIES 192
15.20.1 COMPANY SNAPSHOT 192
15.20.2 PRODUCT PORTFOLIO 192
15.20.3 RECENT DEVELOPMENT 192
15.20.3.1 R&D FACILITY 192
15.21 ZIEMER OPHTHALMIC SYSTEMS 193
15.21.1 COMPANY SNAPSHOT 193
15.21.2 PRODUCT PORTFOLIO 193
15.21.3 RECENT DEVELOPMENT 193
15.21.3.1 AGREEMENT 194
16 QUESTIONNAIRE 195
17 RELATED REPORTS 199